openPR Logo
Press release

Benign Prostatic Hyperplasia (BPH) And Prostate Treatment Market Forecast By End-use Industry 2016-2026

08-24-2016 08:29 AM CET | Health & Medicine

Press release from: Future Market Insights

Benign Prostatic Hyperplasia (BPH) And Prostate Treatment

Benign prostatic hyperplasia (BPH) is also known as benign prostatic hypertrophy or benign prostatic obstruction. Benign prostatic hyperplasia (BPH) is a health condition in men in which the prostate gland size is enlarged than a normal. In a men whole life, prostate grows in two phases, first phase is occurs in early stage of puberty, second phase starts at the age of twenty five and it continues most of persons life. BPH occurs in second phase of growth and it is very general problem in a men who are above age 50. In 2010, 14 Mn men in the U.S. diagnosed with BPH. However, BPH may occurs in before age 40 and the chances of BPH will increase with age.

If prostate gland enlarges than its normal size, the gland presses in between pinches and the urethra. As a result, the bladder wall become thicker and lose the ability to empty the bladder completely. Symptoms of BPH include urinary frequency, nocturia and urinary incontinence. BPH may causes urinary tract infections, bladder damage, and kidney damage in an acute stage.

To treat BPH, medications, minimally invasive procedures and surgeries are available. Medications are used to shrink the prostate gland and reduce the symptoms of BPH, minimally invasive procedures and surgeries performed when medication is ineffective.

Benign Prostatic Hyperplasia (BPH) and Prostate Treatment Market: Drivers and Restraints

Benign Prostatic Hyperplasia (BPH) treatment market driven by increasing ageing population around world. Increasing incidence rates of BPH also expected to drive the overall benign prostatic hyperplasia market.

Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1664

Availability of different treatment procedures to treat benign prostatic hyperplasia and prostate treatment also expected to drive the BPH market during the forecast period.

Benign Prostatic Hyperplasia (BPH) and Prostate Treatment Market: Segmentation

Benign Prostatic Hyperplasia (BPH) and Prostate Treatment Market is segmented into following types

By Treatment

Medication

Alpha blockers

Phosphodiesterase-5 inhibitors

Combination medications

Minimally invasive surgeries

Transurethral Needle Ablation

Transurethral Microwave Thermotherapy

High-Intensity Focused Ultrasound

Transurethral Electrovaporization

Water-Induced Thermotherapy

Prostatic Stent Insertion

Surgeries

By End User

Hospitals

Ambulatory Surgery Centers

Hospital Pharmacies

Retail Stores

Benign Prostatic Hyperplasia (BPH) and Prostate Treatment Market: Overview

Increasing healthcare awareness among mass population along with rise in prevalence rate of benign prostatic hyperplasia (BPH) is expected to propel the overall demand for (BPH) and prostate treatment market. The market is expected to witness a healthy growth over the forecast period (2016-2026)

Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1664

Benign Prostatic Hyperplasia (BPH) and Prostate Treatment Market: Region- wise OutlooK

Depending on geographic regions, the global benign prostatic hyperplasia (BPH) and prostate treatment market is segmented into seven key regions: North America, Latin America, Eastern Europe, Western Europe, Asia Pacific excluding Japan, Japan and Middle East & Africa.

BPH market is mainly depend on the ageing population. Among all regions, Europe and Asia Pacific are expected to witness a high growth rate over the forecast period owing to the large number of ageing population in these regions. North America and Latin America also expected to witness a healthy growth rate during the forecast period.

Benign Prostatic Hyperplasia (BPH) and Prostate Treatment Market: Key Players

Some of the key players in this market are

Sanofi Aventis

Sandoz Inc

Watson Laboratories Inc

Labopharm Inc

Teva Pharmaceuticals Usa Inc

Pfizer Inc

ABOUT US:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

CONTACT:
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Benign Prostatic Hyperplasia (BPH) And Prostate Treatment Market Forecast By End-use Industry 2016-2026 here

News-ID: 358160 • Views:

More Releases from Future Market Insights

Global Lithium Ion Battery Separator Market Projected to Reach US$ 3,256.7 Million by 2032
Global Lithium Ion Battery Separator Market Projected to Reach US$ 3,256.7 Milli …
The lithium-ion battery separator is a critical component in lithium-ion batteries, responsible for preventing short circuits and ensuring safe and efficient battery performance. It acts as a physical barrier between the positive and negative electrodes, allowing lithium ions to pass through while blocking the flow of electrons. With advancements in separator technology, these separators play a key role in enhancing battery capacity, cycle life, and overall safety in various applications,
Industrial Drums Market on a Trajectory to Reach US$ 17.6 Billion by 2027, Bolstered by a Robust 7.1% CAGR from 2022
Industrial Drums Market on a Trajectory to Reach US$ 17.6 Billion by 2027, Bolst …
The Industrial Drums Market is experiencing a steady and promising trajectory, with an estimated value of US$ 12.5 billion in 2022, projected to escalate to US$ 17.6 billion by 2027 at a commendable Compound Annual Growth Rate (CAGR) of 7.1%. This growth is substantiated by a 6.6% CAGR in volume during 2022-27, as per Future Market Insights. Anticipated to expand 1.5 times within this period, the market presents alluring prospects for industry
Supermarkets, Convenience Stores, and Eco-friendly Choices Fuel the Expansion of the Metal Cans Industry, Catering to Health-conscious and Environmentally-aware Consumers
Supermarkets, Convenience Stores, and Eco-friendly Choices Fuel the Expansion of …
The metal cans market is predicted to grow at a CAGR of 5% over the forecast period, according to research by Future Market Insights. The industry's estimated value is expected to increase from US$ 56 Bn in 2023 to US$ 91.1 Bn by 2033. The market for metal cans has been driven by the heightened demand for the product in food and beverages industry. Metal cans helps prolong shelf-life of perishable
Folding IBCs Market Poised for Growth: Expected to Reach US$ 528 Million by 2027 with a 4.8% CAGR
Folding IBCs Market Poised for Growth: Expected to Reach US$ 528 Million by 2027 …
The folding intermediate bulk containers (IBCs) market is on a growth trajectory, with an estimated value of US$ 418 million in 2022, projected to reach US$ 528 million by 2027, showcasing a Compound Annual Growth Rate (CAGR) of 4.8%. Remarkably, the China folding IBCs market defied initial pandemic-related skepticism and is anticipated to grow by 6.9% year on year in 2022. Despite global challenges, China's folding IBCs market is poised to contribute

All 5 Releases


More Releases for BPH

Elderly Men Creating Huge Requirement for BPH Treatment Drugs and Devices
Benign prostatic hyperplasia (BPH) or prostate gland enlargement is caused due to urinary tract infections, bladder or kidney stones, prostatitis, urethral stricture, bladder or prostate cancer, and scarring in the bladder neck caused due to previous surgeries. The common signs and symptoms of BPH include frequent urination, nocturia, difficulty in initiating urination, dribble at the end of urination, and inability to empty the bladder. This disease is highly prevalent among
Benign prostatic hyperplasia: BPH drugs versus Dr Allen’s Device
The Global Treatment Market of Benign prostatic hyperplasia (BPH) was valued at $10,688.72 million in 2017 and is projected to reach $20,096.68 million by 2025 at a CAGR of 8.1% from 2018 to 2025. Thermobalancing therapy with Dr Allen’s Device was patented by the United States Patent and Trademark Office. Over a decade, thousands of men with BPH used or are using this non-invasive and side-effects free Dr Allen’s Device.
Benign Prostatic Hyperplasia (BPH) Procedures Insights, Potential Business Strat …
Increasing life expectancy and fall in the birth rates are the major reasons for rise in the aging population. The people in this category require extensive care, since they are more prone to illness due to low immunity levels and longer recovery time. Increase in the aging population in the U.S., Germany, China and India in the next few years, is expected to create high demand for BPH treatment devices,
Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Trends, Technologica …
Benign Prostatic Hyperplasia (BPH) refers to an enlarged prostate gland. The prostate gland surrounds the urethra, the tube that carries urine from the bladder out of the body. Enlargement of prostate gland leads to blockage in urethra, thus causing problems during urination. It involves glandular and stromal epithelial hyperplasia, which occurs in the peri-urethral transition zone surrounding the urethra. Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/bph-treatment-devices-market BPH is common in aging men,
Benign Prostatic Hyperplasia (BPH) And Prostate Treatment Market Industry Trends …
Benign prostatic hyperplasia (BPH) is also known as benign prostatic hypertrophy or benign prostatic obstruction. Benign prostatic hyperplasia (BPH) is a health condition in men in which the prostate gland size is enlarged than a normal. In a men whole life, prostate grows in two phases, first phase is occurs in early stage of puberty, second phase starts at the age of twenty five and it continues most of persons
US Benign Prostatic Hyperplasia (BPH) Procedures - Development, Growth and Forec …
Increase in the aging population in the U.S in the next few years, is expected to create high demand for BPH treatments, since the population aged 50 years and above is more prone to BPH, and therefore tend to opt for various treatments that involve the use of procedures such as TURP, TUIP and laser based treatments. According to the National Institute of Health, it has been estimated that around